Repligen CEO says Spectrum acquisition fills gap in bioprocessing product line
Repligen Corporation has announced it will acquire filtration-focused Spectrum Pharmaceuticals for approximately $350m (€312m).
Archives for June 26, 2017
OSE Immunotherapeutics halts recruitment in cancer vaccine trial
OSE Immunotherapeutics SA has halted recruitment in a Phase III trial of its cancer vaccine Tedopi (OSE2101).
Lonza’s $5.5bn Capsugel takeover cleared by regulators
Lonza expects to complete its $5.5bn (€5.2bn) takeover of Capsugel SA in the next few days having secured approval from competition authorities around the world.